Sanger sequencing for 50 reactions

The University of Virginia awarded contract A207_PO-0417134-V3 to AZENTA US, INC. on August 15, 2026, with a total contract value of $297. The primary deliverable under this contract consists of Sanger sequencing services, a molecular biology analytical technique used for DNA sequence determination. The contract specifies a quantity of 297 reactions at a unit price of $1 per reaction, with delivery to the contracting organization's designated buyer location.

AZENTA US, INC. is obligated to provide the Sanger sequencing services as the prime contractor under this Virginia state contract. While the specific performance location and contract performance period are not explicitly detailed in the award documentation, the contracting organization's location in Charlottesville, Virginia, serves as the primary point of delivery. The modest contract value and standardized unit pricing structure indicate this engagement represents a specialized scientific service procurement, likely supporting research or diagnostic operations within the University of Virginia's academic or medical infrastructure.